罗欣药业(002793.SZ)拟受让北京健康少数股东19.05%股权

Core Viewpoint - The company intends to acquire a 19.0526% stake in Beijing Health from Chengdu Deyixin Huaxin Investment Partnership for 67.56052 million yuan, increasing its ownership in Beijing Health from 80.9474% to 100% [1] Group 1: Acquisition Details - The acquisition will be funded through the company's own or raised funds [1] - The stake corresponds to Chengdu Deyixin's paid-in capital of 67.37 million yuan [1] Group 2: Company Background - Beijing Health was established in December 2020 and serves as the sales and promotion platform for the company's main products [1] - The company focuses on the circulation of high-quality pharmaceuticals in the fields of digestive and anti-infective drugs [1] Group 3: Financial Performance and Strategic Rationale - Beijing Health has achieved profitability and its future profit potential and operational risks are reliably estimable [1] - The acquisition is aimed at optimizing resource allocation, enhancing decision-making efficiency, and promoting synergistic development with quality subsidiaries [1] - This move aligns with the company's long-term development strategy [1]